Literature DB >> 19342790

Crystallization and preliminary X-ray analysis of a rat aldose reductase-like protein (AKR1B14).

Roland Chung1, Satoshi Endo, Akira Hara, Ossama El-Kabbani.   

Abstract

Mouse vas deferens protein/aldo-keto reductase 1B7 (AKR1B7) is involved in the detoxification of isocaproaldehyde, a steroidogenesis byproduct, and of 4-hydroxynonenal formed by lipid peroxidation. The rat orthologue of AKR1B7 has recently been named AKR1B14 in the AKR superfamily. Recombinant AKR1B14 was expressed in a bacterial system and purified to homogeneity. The purified protein was crystallized from polyethylene glycol solutions using the hanging-drop vapour-diffusion method and an X-ray diffraction data set was collected to 1.86 A resolution. The crystals belonged to space group P2(1), with unit-cell parameters a = 50.66, b = 69.14, c = 72.27 A, beta = 96.4 degrees. This is the first crystallization report of a rodent AKR1B7 orthologue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342790      PMCID: PMC2664770          DOI: 10.1107/S1744309109009762

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  26 in total

Review 1.  Aldose reductase and the role of the polyol pathway in diabetic nephropathy.

Authors:  M Dunlop
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

2.  Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family.

Authors:  D J Hyndman; T G Flynn
Journal:  Biochim Biophys Acta       Date:  1998-08-20

Review 3.  Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.

Authors:  C Yabe-Nishimura
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

4.  Identification and characterization of a novel human aldose reductase-like gene.

Authors:  D Cao; S T Fan; S S Chung
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

5.  Luteinizing hormone induces mouse vas deferens protein expression in the murine ovary.

Authors:  E Brockstedt; M Peters-Kottig; V Badock; C Hegele-Hartung; M Lessl
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

6.  Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells.

Authors:  A M Lefrançois-Martinez; C Tournaire; A Martinez; M Berger; S Daoudal; D Tritsch; G Veyssière; C Jean
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

7.  Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase.

Authors:  S Srivastava; T M Harter; A Chandra; A Bhatnagar; S K Srivastava; J M Petrash
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

8.  Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland.

Authors:  E T Lau; D Cao; C Lin; S K Chung; S S Chung
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

9.  Cyclic AMP regulates expression of the gene coding for a mouse vas deferens protein related to the aldo-keto reductase superfamily in human and murine adrenocortical cells.

Authors:  C Aigueperse; A Martinez; A M Lefrançois-Martinez; G Veyssière; C I Jean
Journal:  J Endocrinol       Date:  1999-01       Impact factor: 4.286

10.  1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor.

Authors:  D K Wilson; T Nakano; J M Petrash; F A Quiocho
Journal:  Biochemistry       Date:  1995-11-07       Impact factor: 3.162

View more
  1 in total

1.  Structure of the His269Arg mutant of the rat aldose reductase-like protein AKR1B14 complexed with NADPH.

Authors:  Krithika Sundaram; Satoshi Endo; Toshiyuki Matsunaga; Nobutada Tanaka; Akira Hara; Ossama El-Kabbani
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-03-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.